We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Acoustic Mass Spectrometry for Screening Biological Targets

Jonathan Wingfield, Principal Scientist at AstraZeneca, describes how acoustic mass spectrometry technology being used to screen biological targets.